Clinical Trial Update: Post-market Study on TrHCROSS® in Knee Osteoarthritis After a Single Injection [NA]

View source ↗

Summary

A post-market study evaluating TrHCROSS® after a single intra-articular knee injection for knee osteoarthritis has completed. The sponsor is i+Med S.Coop.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Knee Osteoarthritis

Drugs mentioned

• TrHCROSS

Snippet

Sponsor: i+Med S.Coop. | Conditions: Knee Osteoarthritis | NA | Status: COMPLETED